Scientific Reports | 2021

Insulin micro-secretion in Type 1 diabetes and related microRNA profiles

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Abstract


The aim of this cross-sectional study was to compare plasma C-peptide presence and levels in people without diabetes (CON) and with Type 1 diabetes and relate C-peptide status to clinical factors. In a subset we evaluated 50 microRNAs (miRs) previously implicated in beta-cell death and associations with clinical status and C-peptide levels. Diabetes age of onset was stratified as adult (≥\u200918 y.o) or childhood (<\u200918 y.o.), and diabetes duration was stratified as\u2009≤\u200910 years, 10–20 years and\u2009>\u200920 years. Plasma C-peptide was measured by ultrasensitive ELISA. Plasma miRs were quantified using TaqMan probe-primer mix on an OpenArray platform. C-peptide was detectable in 55.3% of (n\u2009=\u2009349) people with diabetes, including 64.1% of adults and 34.0% of youth with diabetes, p\u2009<\u20090.0001 and in all (n\u2009=\u2009253) participants without diabetes (CON). C-peptide levels, when detectable, were lower in the individuals with diabetes than in the CON group [median lower quartile (LQ)–upper quartile (UQ)] 5.0 (2.6–28.7) versus 650.9 (401.2–732.4) pmol/L respectively, p\u2009<\u20090.0001 and lower in childhood versus adult-onset diabetes [median (LQ–UQ) 4.2 (2.6–12.2) pmol/L vs. 8.0 (2.3–80.5) pmol/L, p\u2009=\u20090.02, respectively]. In the childhood-onset group more people with longer diabetes duration (>\u200920 years) had detectable C-peptide (60%) than in those with shorter diabetes duration (39%, p for trend\u2009<\u20090.05). Nine miRs significantly correlated with detectable C-peptide levels in people with diabetes and 16 miRs correlated with C-peptide levels in CON. Our cross-sectional study results are supportive of (a) greater beta-cell function loss in younger onset Type 1 diabetes; (b) persistent insulin secretion in adult-onset diabetes and possibly regenerative secretion in childhood-onset long diabetes duration; and (c) relationships of C-peptide levels with circulating miRs. Confirmatory clinical studies and related basic science studies are merited.

Volume 11
Pages None
DOI 10.1038/s41598-021-90856-6
Language English
Journal Scientific Reports

Full Text